Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-19-022160
Date:2019-08-16
Issuer: CLOVIS ONCOLOGY, INC. (CLVS)
Original Submission Date:

Reporting Person:

BLAIR JAMES C
C/O DOMAIN ASSOCIATES, LLC
202 CARNEGIE CENTER, SUITE 104 PRINCETON, NJ 08540

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-08-16 P 20,000 a $5.70 33,439 direct
COMMON STOCK 2019-08-20 P 20,000 a $5.97 20,000 indirect f3
COMMON STOCK 2019-08-16 0 $0.00 10,105 indirect f4
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $5.65 to $5.73. the reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $5.88 to $6.09. the reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
f3 the reporting person disclaims beneficial ownership of such shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares for purposes of section 16 or for any other purpose.
f4 the reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
WhaleWisdom Logo

Elevate your investments